Haarlem, Netherlands

Johan Keegstra

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Pharmachemie B.v.. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan Keegstra. Retrieved from https://idiyas.com/inventor/johan-keegstra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • GA Haarlem, NL (2021)
  • Haarlem, NL (2021 - 2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Johan Keegstra

Introduction

Johan Keegstra is a notable inventor based in Haarlem, Netherlands. He has made significant contributions to the field of inhalation therapy, particularly through his innovative designs in dry powder inhalers. With a total of three patents to his name, Keegstra's work has the potential to improve the delivery of medication for respiratory conditions.

Latest Patents

One of Johan Keegstra's latest patents is a dry powder inhaler that incorporates a budesonide/formoterol formulation. This invention features a reservoir containing a dry powder formulation and a mechanism for delivering a metered dose of the medicament. Additionally, it includes a cyclone deagglomerator designed to break up agglomerates of the dry powder medicament. The delivery passageway directs inhalation-induced airflow through a mouthpiece, ensuring effective medication delivery. The inhalable β2-agonist in this invention has a specific particle size distribution, which enhances its efficacy.

Career Highlights

Keegstra has established himself as a key figure in the pharmaceutical industry, particularly through his work at Pharmachemie B.V. His innovative approach to inhalation devices has garnered attention and recognition within the field. His patents reflect a commitment to advancing respiratory therapies and improving patient outcomes.

Collaborations

Johan Keegstra has collaborated with several professionals in his field, including Michael Imre Goller and Jan Arp. These collaborations have likely contributed to the development and refinement of his innovative inventions.

Conclusion

Johan Keegstra's contributions to inhalation therapy through his patents demonstrate his dedication to improving healthcare solutions. His work continues to influence the field and offers promising advancements for patients requiring respiratory medication.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…